Lyell Immunopharma, Inc. Common Stock LYEL
$15.43
+43.27%
at last close
Analyst Consensus
- Consensus Rating
- Buy (5 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $40.60
- Implied Upside
- +163.1%
- Price Target Range
- $34.00 – $45.00
- Analysts (12 mo)
- 5
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-11-03 | NeedhamGil Blum |
Reiterates | Buy | $44 |
| 2026-09-11 | NeedhamGil Blum |
Reiterates | Buy | $44 |
| 2026-08-06 | StifelStephen Willey |
Initiates coverage on | Buy | $36 |
| 2026-07-22 | B. Riley SecuritiesYuan Zhi |
Initiates coverage on | Buy | $44 |
| 2026-06-15 | CitizensReni J. Benjamin |
Reiterates | Market outperform | $34 |
| 2026-06-15 | NeedhamGil Blum |
Reiterates | Buy | $44 |
| 2026-06-09 | HC Wainwright & Co.Mitchell S. Kapoor |
Reiterates | Buy | $45 |
| 2026-06-08 | NeedhamGil Blum |
Reiterates | Buy | $44 |
| 2026-06-03 | HC Wainwright & Co.Mitchell S. Kapoor |
Reiterates | Buy | $45 |
| 2026-05-07 | NeedhamGil Blum |
Reiterates | Buy | $44 |
| 2026-04-10 | NeedhamGil Blum |
Initiates coverage on | Buy | $44 |
| 2026-03-09 | CitizensReni J. Benjamin |
Initiates coverage on | Market outperform | $34 |
| 2025-12-09 | HC Wainwright & Co.Mitchell S. Kapoor |
Upgrades | Neutral → Buy | $20 → $45 |
| 2025-11-24 | HC Wainwright & Co.Mitchell S. Kapoor |
Maintains | Neutral | $10 → $20 |
| 2025-09-26 | LUCID CAPITAL MARKETSChristopher Liu |
Initiates coverage on | Buy | $20 |
| 2025-06-24 | HC Wainwright & Co.Mitchell Kapoor |
Maintains | Neutral | $1 → $10 |
| 2025-04-16 | HC Wainwright & Co.Mitchell Kapoor |
Reiterates | Neutral | $1 |
| 2025-03-13 | HC Wainwright & Co.Mitchell Kapoor |
Reiterates | Neutral | $1 |
| 2024-11-12 | HC Wainwright & Co.Mitchell Kapoor |
Reiterates | Neutral | $1 |
| 2024-10-30 | B of A SecuritiesGeoff Meacham |
Downgrades | Buy → Underperform | $6 → $1 |
| 2024-10-28 | HC Wainwright & Co.Mitchell Kapoor |
Reiterates | Neutral | $1 |
| 2024-08-19 | HC Wainwright & Co.Mitchell Kapoor |
Reiterates | Neutral | $1 |
| 2024-06-27 | B of A SecuritiesGeoff Meacham |
Maintains | Buy | $9 → $6 |
| 2024-06-27 | HC Wainwright & Co.Mitchell Kapoor |
Downgrades | Buy → Neutral | $6 → $1 |
| 2024-05-07 | HC Wainwright & Co.Mitchell Kapoor |
Reiterates | Buy | $6 |
| 2024-02-29 | HC Wainwright & Co.Mitchell Kapoor |
Maintains | Buy | $8 → $6 |
| 2023-11-09 | HC Wainwright & Co.Mitchell Kapoor |
Maintains | Buy | $9 → $8 |
| 2023-08-28 | JP MorganEric Joseph |
Downgrades | Overweight → Neutral | $15 → $5 |
| 2023-05-05 | HC Wainwright & Co.Mitchell Kapoor |
Reiterates | Buy | $9 |
| 2023-03-02 | HC Wainwright & Co.Mitchell Kapoor |
Maintains | Buy | $11 → $9 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $15.43
- Market Cap
- $263.92 million
- 52-Week Range
- $7.20 – $45.00
- Average Volume
- 183K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.